Epoprostenol for very low birth weight (VLBW) infants: a novel dilution protocol


Submitted: 17 November 2014
Accepted: 17 November 2014
Published: 31 October 2013
Abstract Views: 859
PDF: 1005
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • S. Rugolotto Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • R. Beghini Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • I. Cogo Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • G. Sidoti Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • E.M. Padovani Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • A. Pietrobelli Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
Epoprostenol has been the first effective treatment for severe pulmonary arterial hypertension. Epoprostenol is provided in vials for adult therapy. To our knowledge there are no reports on specific dilution protocols for epoprostenol in VLBW infants, when very small infusion rates are required. We describe the dilution protocol we applied to a preterm infant who was born at 30 weeks of gestational age with a weight of 1.000 g. Our dilution protocol keeps the recommended dilution ratios, and the required solution pH, for very small dosages of epoprostenol, using the same diluent vial. Our method allows a correct and safe administration of epoprostenol in VLBW infants.

Rugolotto, S., Beghini, R., Cogo, I., Sidoti, G., Padovani, E., & Pietrobelli, A. (2013). Epoprostenol for very low birth weight (VLBW) infants: a novel dilution protocol. La Pediatria Medica E Chirurgica, 35(5). https://doi.org/10.4081/pmc.2013.31

Downloads

Download data is not yet available.

Citations